news
Researchers have used CRISPR-Cas9 to screen the genome for possible…
26 March 2020 | By Victoria Rees (Drug Target Review)
Researchers have used CRISPR-Cas9 to screen the genome for possible targets that could be used in potential treatments for muscular dystrophy.